Clinical Trial Update: Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing Laparoscopy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing intraperitoneal, tissue, and serum concentrations of VML-0501 after vaginal dosing to oral danazol in women with endometriosis undergoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• VML-0501 (danazol)

Snippet

Sponsor: Viramal Limited | Conditions: Endometriosis | Phase 2 | Status: COMPLETED